cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.2r3y8x
title: Occurrence Download

description: A dataset containing 624334 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Alnus glutinosa (L.) Gaertn."
 ]
}

 The dataset includes 624334 records from 1016 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0283427-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.14286572.v1
title: Adjunctive medical expulsive therapy with tamsulosin for repeated extracorporeal shock wave lithotripsy: a systematic review and meta-analysis

description: ABSTRACT Purpose: To evaluate the efficacy of adjunctive medical expulsive therapy (MET) with tamsulosin for the promotion of stone fragments clearance for repeated extracorporeal shock wave lithotripsy (ESWL). Materials and Methods: This meta-analysis was conducted by systematic search for randomized controlled trial (RCT) studies in PubMed/Medline, Scopus, Cochrane Library, Web of Science databases in January 2020, which compared tamsulosin with either placebo or non-placebo control for repeated ESWL. The primary endpoint was stone-free rate (SFR), the second endpoints were stone clearance time and complications. The quality assessment of included studies was performed by using the Cochrane System and Jadad score. Results: 7 RCTs were included in this meta-analysis. Tamsulosin provided higher SFR (for stones larger than 1cm, OR: 5.56, p=0.0003), except for patients with stones less than 1cm. For patients with renal stones (OR: 2.97, p=0.0005) or upper ureteral stones (OR: 3.10, p=0.004), tamsulosin can also provide a higher SFR. In addition, tamsulosin provided a shorter stone clearance time (WMD: −9.40, p=0.03) and lower pain intensity (WMD=-17.01, p &lt;0.0001) and incidences of steinstrasse (OR: 0.37, p=0.0002). Conclusion: Adjunctive MET with tamsulosin is effective in patients with specific stone size or location that received repeated ESWL. However, no well-designed RCT that used computed tomography for the detection and assessment of residual stone fragments was found. More studies with high quality and the comparison between tamsulosin and secondary ESWL are needed in the future.
DOI: 10.6084/m9.figshare.14286530
title: Special strategies and management of urological diseases during the COVID-19 Pandemic: initial experiences from a Medical Center of China

description: ABSTRACT Although urological diseases are not directly related to coronavirus disease 2019 (COVID-19), urologists need to make comprehensive plans for this disease. Urological conditions such as benign prostatic hyperplasia and tumors are very common in elderly patients. This group of patients is often accompanied by underlying comorbidities or immune dysfunction. They are at higher risk of COVID-19 infection and they tend to have severe manifestations. Although fever can occur along with urological infections, it is actually one of the commonest symptoms of COVID-19; urologists must always maintain a high index of suspicion in their clinical practices. As a urological surgeon, how we can protect medical staff during surgery is a major concern. Our hospital had early adoption of a series of strict protective and control measures, and was able to avoid cross-infection and outbreak of COVID-19. This paper discusses the effective measures that can be useful when dealing with urological patients with COVID-19.
DOI: 10.6084/m9.figshare.14286530.v1
title: Special strategies and management of urological diseases during the COVID-19 Pandemic: initial experiences from a Medical Center of China

description: ABSTRACT Although urological diseases are not directly related to coronavirus disease 2019 (COVID-19), urologists need to make comprehensive plans for this disease. Urological conditions such as benign prostatic hyperplasia and tumors are very common in elderly patients. This group of patients is often accompanied by underlying comorbidities or immune dysfunction. They are at higher risk of COVID-19 infection and they tend to have severe manifestations. Although fever can occur along with urological infections, it is actually one of the commonest symptoms of COVID-19; urologists must always maintain a high index of suspicion in their clinical practices. As a urological surgeon, how we can protect medical staff during surgery is a major concern. Our hospital had early adoption of a series of strict protective and control measures, and was able to avoid cross-infection and outbreak of COVID-19. This paper discusses the effective measures that can be useful when dealing with urological patients with COVID-19.
DOI: 10.6084/m9.figshare.14286584.v1
title: Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis

description: ABSTRACT Purpose: Radical nephrectomy (RN) is the standard surgical type for pathological stage T3a (pT3a) renal cell carcinoma (RCC). Recently, some studies have suggested equivalence between partial nephrectomy (PN) and RN for oncologic control and have shown the benefits of PN for better renal function. We conducted this meta-analysis to assess oncologic outcomes, perioperative outcomes and renal function between two groups among patients with pT3a RCC. Materials and methods: PubMed, Scopus, Web of Science, Science Direct, Ovid MEDLINE, The Cochrane Library, Embase and Google Scholar were searched for eligible articles. The endpoints of the final analysis included overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), surgical complications, operative time, estimated blood loss (EBL), serum creatinine and estimated glomerular filtration rate (eGFR). Results: Twelve studies of moderate to high quality, including 14.152 patients, were examined. PN showed superiority for renal functional preservation, providing higher eGFR (WMD=12.48mL/min; 95%CI: 10.28 to 14.67; P &lt;0.00001) and lower serum creatinine (WMD=-0.31mg/dL; 95%CI: −0.40 to −0.21; P &lt;0.00001). There were no significant differences between PN and RN regarding operative time, EBL, surgical complications, OS, RFS and CSS. Despite inherent selection bias, most pooled estimates were consistent in sensitivity analysis and subgroup analysis. More positive margins were found in the PN group (RR=2.42; 95%CI: 1.25-4.68; P=0.009). Conclusions: PN may be more suitable for treating pT3a RCC than RN because it provides a similar survival time (OS or RFS) and superior renal function. Nevertheless, this result is still disputed, and more high-quality studies are required.
DOI: 10.6084/m9.figshare.16907255
title: Additional file 5 of Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer

description: Additional file 5: Supplementary Table 3. The compositions of different FR risk signatures derived from five research
DOI: 10.6084/m9.figshare.16907215.v1
title: Additional file 8 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 8: Table S7. Conditional analysis for independence of associations. Conditional analysis was performed on the PGC schizophrenia data, the UK Biobank BMI data, as well as two BioVU clinical trait associations (16p11.2 genes and psychosis, 22q11.2 genes and morbid obesity). For each trait, we performed MultiXcan first adjusting for a specific gene, then by leaving a gene in and adjusting all the other genes associated with that trait out. The Pcond reported in the text is the p-value of this gene-trait pair when adjusting for all other genes considered for conditioning for this trait, unless otherwise stated.
DOI: 10.6084/m9.figshare.16907218.v1
title: Additional file 9 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 9: Table S8. Traits over-represented in CNV carriers. The four categories of CNV carrier – 16p11.2 duplication, 16p11.2 deletion, 22q11.2 duplication, 22q11.2 deletion – were tested separately. The results for all clinical traits tested are provided. The number of cases and controls for each trait is given, as well as whether the p-value meets either Bonferroni or FDR correction. Traits in bold were represented in over 5% of carriers.
DOI: 10.6084/m9.figshare.16907185
title: Additional file 10 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 10: Table S9. Top PheWAS associations of 16p11.2 and 22q11.2 genes. The top 15 associated traits for each gene, regardless of p-value, are shown. These represent the top 1% of associations among all traits tested. Genes are listed in alphabetical order, with each trait’s sample size and phecode noted [80].
DOI: 10.6084/m9.figshare.16907185.v1
title: Additional file 10 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 10: Table S9. Top PheWAS associations of 16p11.2 and 22q11.2 genes. The top 15 associated traits for each gene, regardless of p-value, are shown. These represent the top 1% of associations among all traits tested. Genes are listed in alphabetical order, with each trait’s sample size and phecode noted [80].
DOI: 10.6084/m9.figshare.16907194.v1
title: Additional file 1 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 1: Table S1. List of genotyped discovery and replication cohorts used in the study. List of datasets used for discovery and replication of association results with sample sizes. The specific cohorts from the Psychiatric Genomics Consortium that were used for this analysis are listed. All variables from the UK Biobank that were used for replication are shown.
DOI: 10.6084/m9.figshare.16907188.v1
title: Additional file 11 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 11: Table S10. Enrichment of clinical categories among the top PheWAS associations. The top 15 traits (codes) for each gene analyzed (n = 1470 gene-trait pairs) were divided into 17 clinical categories (observed counts column). The values in the expected counts column are calculated as 1470 * {the proportion of traits of that category tested}. For example, 159 out of 1531 codes tested were from the “circulatory system” category, so the expected counts for “circulatory system” are calculated as 1470*159/1531. The last column contains the p-value from a binomial test comparing whether the observed proportion of clinical categories is more extreme than expected.
DOI: 10.6084/m9.figshare.16907194
title: Additional file 1 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 1: Table S1. List of genotyped discovery and replication cohorts used in the study. List of datasets used for discovery and replication of association results with sample sizes. The specific cohorts from the Psychiatric Genomics Consortium that were used for this analysis are listed. All variables from the UK Biobank that were used for replication are shown.
DOI: 10.6084/m9.figshare.16907212.v1
title: Additional file 7 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 7: Table S6. Comparison of association results to independent data. For each gene-trait pair, we list the original p-value, the GWAS trait(s) that we classified as most similar to a PheWAS trait, its best p-value in an independent dataset, the number of GWAS datasets that were used for this trait, and the rank of this gene within that dataset. For UK Biobank summary statistics, we have genome-wide data; for datasets with individual-level data, only 16p11.2 and 22q11.2 genes were calculated. See Table S2 for more information on datasets used.
DOI: 10.6084/m9.figshare.16907215
title: Additional file 8 of Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes

description: Additional file 8: Table S7. Conditional analysis for independence of associations. Conditional analysis was performed on the PGC schizophrenia data, the UK Biobank BMI data, as well as two BioVU clinical trait associations (16p11.2 genes and psychosis, 22q11.2 genes and morbid obesity). For each trait, we performed MultiXcan first adjusting for a specific gene, then by leaving a gene in and adjusting all the other genes associated with that trait out. The Pcond reported in the text is the p-value of this gene-trait pair when adjusting for all other genes considered for conditioning for this trait, unless otherwise stated.
DOI: 10.13145/bacdive1724.20170425.1
title: Bifidobacterium ruminantium Biavati and Mattarelli 1991

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1725.20170425.1
title: Bifidobacterium ruminantium Biavati and Mattarelli 1991

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1726.20170425.1
title: Bifidobacterium merycicum Biavati and Mattarelli 1991

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1727.20170425.1
title: Bifidobacterium merycicum Biavati and Mattarelli 1991

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2585.20170425.1
title: Clostridium fallax (Weinberg and Seguin 1915) Bergey et al. 1923

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2586.20170425.1
title: Clostridium felsineum (Carbone and Tombolato 1917) Bergey et al. 1939

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2587.20170425.1
title: Clostridium formicaceticum Andreesen et al. 1970

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2589.20170425.1
title: Clostridium formicaceticum Andreesen et al. 1970

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2590.20170425.1
title: Clostridium formicaceticum Andreesen et al. 1970

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2591.20170425.1
title: Clostridium formicaceticum Andreesen et al. 1970

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2592.20170425.1
title: Clostridium formicaceticum Andreesen et al. 1970

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive2593.20170425.1
title: Clostridium formicaceticum Andreesen et al. 1970

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3294.20170425.1
title: Cystobacter fuscus Schroeter 1886

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3295.20170425.1
title: Cystobacter fuscus Schroeter 1886

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3296.20170425.1
title: Cystobacter fuscus Schroeter 1886

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3297.20170425.1
title: Cystobacter fuscus Schroeter 1886

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3298.20170425.1
title: Cystobacter fuscus Schroeter 1886

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3299.20170425.1
title: Cystobacter fuscus Schroeter 1886

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3300.20170425.1
title: Cystobacter armeniaca Reichenbach 2007

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3301.20170425.1
title: Cystobacter armeniaca Reichenbach 2007

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4033.20170425.1
title: Desulfurivibrio alkaliphilus Sorokin et al. 2008

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4034.20170425.1
title: Desulfonatronovibrio hydrogenovorans Zhilina et al. 1997

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4035.20170425.1
title: Desulfonatronovibrio hydrogenovorans Zhilina et al. 1997

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4036.20170425.1
title: Desulfonatronovibrio thiodismutans Sorokin et al. 2011

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4037.20170425.1
title: Desulfonatronovibrio magnus Sorokin et al. 2011

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4038.20170425.1
title: Desulfonatronovibrio halophilus Sorokin et al. 2012

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4039.20170425.1
title: Desulfonauticus submarinus Audiffrin et al. 2003

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive4040.20170425.1
title: Desulfonauticus autotrophicus Mayilraj et al. 2009

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive857.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive858.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive859.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive860.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive861.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive862.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive863.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive864.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive865.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive866.20170425.1
title: Bacillus sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1728.20170425.1
title: Bifidobacterium merycicum Biavati and Mattarelli 1991

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1729.20170425.1
title: Bifidobacterium saeculare Biavati et al. 1992

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1730.20170425.1
title: Bifidobacterium saeculare Biavati et al. 1992

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1731.20170425.1
title: Bifidobacterium saeculare Biavati et al. 1992

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1732.20170425.1
title: Bifidobacterium gallicum Lauer 1990

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1733.20170425.1
title: Bifidobacterium animalis subsp. lactis (Meile et al. 1997) Masco et al. 2004

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1734.20170425.1
title: Bifidobacterium scardovii Hoyles et al. 2002

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive1735.20170425.1
title: Bifidobacterium thermacidophilum subsp. thermacidophilum (Dong et al. 2000) Zhu et al. 2003

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.